我国肿瘤患者多学科诊疗不足，亟待改进

Core Viewpoint - The implementation of a multidisciplinary treatment (MDT) model in cancer care in China has led to improvements in patient outcomes, including a rise in the three-year survival rate from 58% to 66% and a significant reduction in treatment waiting times and hospitalization costs [1][7]. Group 1: Cancer Treatment Efforts - China faces a significant cancer prevention challenge, with 4.82 million new cancer cases reported in 2022, accounting for 24.1% of global new cases [2]. - Efforts to enhance cancer treatment include improving screening and early diagnosis systems, promoting standardized treatment, and accelerating the approval process for new drugs [2][3]. - Despite advancements, the number of patients seeking overseas medical treatment continues to rise, indicating a gap in the perception of treatment quality domestically [2][3]. Group 2: Multidisciplinary Treatment Model - The MDT model involves collaboration among various specialists to create comprehensive treatment plans, which is essential for complex diseases like cancer [6][5]. - Currently, only 16% of top-tier hospitals in China implement the MDT model, highlighting a need for greater awareness and adoption across healthcare facilities [6][7]. - The MDT approach has been shown to improve patient prognosis and survival rates, emphasizing the importance of a collaborative treatment strategy [6][7]. Group 3: Patient Experience and Challenges - Many patients struggle with determining the appropriate treatment options and specialists, indicating a need for better guidance in navigating the healthcare system [2][3]. - The complexity of cancer treatment necessitates input from multiple disciplines, including surgery, radiology, and pathology, to develop effective treatment plans [5][6]. - The current healthcare landscape in China requires a shift towards more personalized and scientifically grounded treatment approaches to enhance patient satisfaction and outcomes [7].